Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily
- PMID: 17364882
- DOI: 10.1080/03602530600969440
Carbonyl reductases and pluripotent hydroxysteroid dehydrogenases of the short-chain dehydrogenase/reductase superfamily
Abstract
Carbonyl reduction of aldehydes, ketones, and quinones to their corresponding hydroxy derivatives plays an important role in the phase I metabolism of many endogenous (biogenic aldehydes, steroids, prostaglandins, reactive lipid peroxidation products) and xenobiotic (pharmacologic drugs, carcinogens, toxicants) compounds. Carbonyl-reducing enzymes are grouped into two large protein superfamilies: the aldo-keto reductases (AKR) and the short-chain dehydrogenases/reductases (SDR). Whereas aldehyde reductase and aldose reductase are AKRs, several forms of carbonyl reductase belong to the SDRs. In addition, there exist a variety of pluripotent hydroxysteroid dehydrogenases (HSDs) of both superfamilies that specifically catalyze the oxidoreduction at different positions of the steroid nucleus and also catalyze, rather nonspecifically, the reductive metabolism of a great number of nonsteroidal carbonyl compounds. The present review summarizes recent findings on carbonyl reductases and pluripotent HSDs of the SDR protein superfamily.
Similar articles
-
Human carbonyl reductases.Curr Drug Metab. 2010 Oct;11(8):639-58. doi: 10.2174/138920010794233530. Curr Drug Metab. 2010. PMID: 20942781 Review.
-
The aldo-keto reductases (AKRs): Overview.Chem Biol Interact. 2015 Jun 5;234:236-46. doi: 10.1016/j.cbi.2014.09.024. Epub 2014 Oct 7. Chem Biol Interact. 2015. PMID: 25304492 Free PMC article. Review.
-
Multiplicity of mammalian reductases for xenobiotic carbonyl compounds.Drug Metab Pharmacokinet. 2006 Feb;21(1):1-18. doi: 10.2133/dmpk.21.1. Drug Metab Pharmacokinet. 2006. PMID: 16547389 Review.
-
Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.Xenobiotica. 2000 Aug;30(8):755-69. doi: 10.1080/00498250050119826. Xenobiotica. 2000. PMID: 11037109
-
A new nomenclature for the aldo-keto reductase superfamily.Biochem Pharmacol. 1997 Sep 15;54(6):639-47. doi: 10.1016/s0006-2952(97)84253-0. Biochem Pharmacol. 1997. PMID: 9310340
Cited by
-
Identification and Functional Analysis of BmNPV-Interacting Proteins From Bombyx mori (Lepidoptera) Larval Midgut Based on Subcellular Protein Levels.Front Microbiol. 2020 Jun 30;11:1481. doi: 10.3389/fmicb.2020.01481. eCollection 2020. Front Microbiol. 2020. PMID: 32695093 Free PMC article.
-
Crystallization of an atypical short-chain dehydrogenase from Vibrio vulnificus lacking the conserved catalytic tetrad.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jul 1;68(Pt 7):771-4. doi: 10.1107/S1744309112018672. Epub 2012 Jun 27. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012. PMID: 22750861 Free PMC article.
-
Structural basis for substrate specificity in human monomeric carbonyl reductases.PLoS One. 2009 Oct 20;4(10):e7113. doi: 10.1371/journal.pone.0007113. PLoS One. 2009. PMID: 19841672 Free PMC article.
-
Salivary amylase induction by tannin-enriched diets as a possible countermeasure against tannins.J Chem Ecol. 2008 Mar;34(3):376-87. doi: 10.1007/s10886-007-9413-z. Epub 2008 Feb 6. J Chem Ecol. 2008. PMID: 18253799
-
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.Clin Cancer Res. 2009 Aug 15;15(16):5258-66. doi: 10.1158/1078-0432.CCR-09-0685. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671875 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous